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Abstract
Background: Since 2000, international funding for HIV has supported scaling up antiretroviral therapy (ART) in
sub-Saharan Africa. However, such funding has stagnated for years, threatening the sustainability and reach of ART
programs amid efforts to achieve universal treatment. Improving health system efficiencies, particularly at the facility
level, is an increasingly critical avenue for extending limited resources for ART; nevertheless, the potential impact of
increased facility efficiency on ART capacity remains largely unknown. Through the present study, we sought to
quantify facility-level technical efficiency across countries, assess potential determinants of efficiency, and predict
the potential for additional ART expansion.
Methods: Using nationally-representative facility datasets from Kenya, Uganda and Zambia, and measures adjusting for
structural quality, we estimated facility-level technical efficiency using an ensemble approach that combined restricted
versions of Data Envelopment Analysis and Stochastic Distance Function. We then conducted a series of bivariate and
multivariate regression analyses to evaluate possible determinants of higher or lower technical efficiency. Finally, we
predicted the potential for ART expansion across efficiency improvement scenarios, estimating how many additional
ART visits could be accommodated if facilities with low efficiency thresholds reached those levels of efficiency.
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Results: In each country, national averages of efficiency fell below 50 % and facility-level efficiency markedly varied.
Among facilities providing ART, average efficiency scores spanned from 50 % (95 % uncertainty interval (UI), 48–62 %)
in Uganda to 59 % (95 % UI, 53–67 %) in Zambia. Of the facility determinants analyzed, few were consistently
associated with higher or lower technical efficiency scores, suggesting that other factors may be more strongly related
to facility-level efficiency. Based on observed facility resources and an efficiency improvement scenario where all
facilities providing ART reached 80 % efficiency, we predicted a 33 % potential increase in ART visits in Kenya, 62 % in
Uganda, and 33 % in Zambia. Given observed resources in facilities offering ART, we estimated that 459,000 new ART
patients could be seen if facilities in these countries reached 80 % efficiency, equating to a 40 % increase in new
patients.
Conclusions: Health facilities in Kenya, Uganda, and Zambia could notably expand ART services if the efficiency with
which they operate increased. Improving how facility resources are used, and not simply increasing their quantity, has
the potential to substantially elevate the impact of global health investments and reduce treatment gaps for people
living with HIV.
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Background
Over 29 million people were living with HIV in 2013,
but due to an unprecedented global response, HIV bur-
den has markedly declined and an estimated 19.1 million
life-years have been saved by interventions such as anti-
retroviral therapy (ART) [1]. This success was fueled by
a rapid escalation of HIV-specific development assist-
ance for health (DAH), rising from $1.4 billion in 2000
to $10.8 billion in 2015 [2, 3]. Yet, HIV funding has plat-
eaued since 2010 and the paradigm for ART is shifting
toward long-term care, diverging from past emergency
response models of care [4]. In September 2015, the
World Health Organization (WHO) revised its ART
guidelines [5], stipulating that everyone living with HIV
should initiate ART irrespective of disease progression.
This update sets universal HIV treatment as an equity-
promoting goal, but also establishes nearly 21 million
people eligible for ART who have yet to receive care [1, 5].
To reach these patients and sustain current ART services
without a guarantee of additional funding, increasing
health system efficiency has emerged as a vital pursuit for
low- and middle-income countries (LMICs) [6, 7].
Scaling up health services involves a complex interplay
of policy levers, as planners must balance improving ac-
cess and equitable provision of care within operational
and financial constraints. A focus on efficiency has
become particularly attractive for expanding ART in
LMICs, as increasing efficiency represents a feasible av-
enue for elevating service production without a propor-
tional rise in expenditures [8, 9]. Otherwise, expanding
care hinges upon more government spending, increased
DAH, or heightened out-of-pocket payments for patients
– and recent projections point to relatively minimal in-
creases in government health spending by LMICs
through 2040 [10]. Technical efficiency refers to the re-
lationship between a health facility’s inputs and outputs
[11], with efficient facilities defined as those using their
inputs to generate the largest quantity of outputs. From
an output-oriented perspective, an inefficient health
facility is one where its resources are not fully maxi-
mized, leaving usable beds empty or providers seeing
few patients each day. Such inefficiencies, when ag-
gregated up through health systems, can represent
millions of missed opportunities to provide care and
health dollars lost. WHO estimates that up to 40 % of
health spending is wasted by system inefficiencies in
LMICs [12], suggesting that substantial cost-savings and
service expansion could occur if improving efficiency was
prioritized.
Over the last 15 years, several studies have assessed
the technical efficiency of health facilities in sub-Saharan
Africa [13–31], quantifying opportunities for efficiency
gains across levels of care. However, past work has
largely focused on one type of facility or region, which
may not reflect a country’s broader health system cap-
acity. Facilities with incomplete input and output re-
cords are often excluded, heightening the risk for biased
estimates of efficiency; for instance, facilities with more
complete data may benefit from higher-quality resources
and facility processes [32]. To date, few studies specific-
ally evaluate the technical efficiency of facilities that
offer ART. Two recent studies measured the efficiency
of facilities providing ART in Rwanda and Zambia [27, 28],
but each had samples with fewer than 35 facilities. Finally,
such efficiency analyses for LMICs infrequently account
for the quality of outputs facilities generate [30]. This is
an area of particular concern for policymakers and pro-
viders alike, as increasing healthcare production in the
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absence of essential medical supplies and infrastructure
will neither improve patient outcomes nor overall pro-
gram sustainability.
For our analysis, we used new efficiency measurement
methods specifically adapted for LMICs [33] to assess
the technical efficiency of health facilities in Kenya,
Uganda, and Zambia. Facility data originated from the
Access, Bottlenecks, Costs, and Equity (ABCE) project, a
multi-country study where data were collected from
stratified random samples of country facility rosters [34].
These datasets capture inputs and outputs, including
ART volumes, from hundreds of facilities, and explicitly
link these data to information on stocks of medical sup-
plies and various structural characteristics. Such linkages
allowed us to construct output-specific indicators of struc-
tural quality, which served as proxy for service quality
[31]. Based on efficiency estimates from facilities providing
ART, we predicted the potential for ART service expan-
sion across efficiency improvement scenarios. Recognizing
current evidence gaps on efficiency in LMICs, we sought
to quantify the capacity for providing more ART through
gains in efficiency.
Methods
Data
We used nationally-representative facility data from
Kenya, Uganda, and Zambia [35–37]. Facility data col-
lection occurred from September 2011 to April 2012 for
Zambia, and April to November 2012 for Kenya and
Uganda. Each country dataset included publicly- and
privately-owned facilities across levels of care, and pro-
vided retrospective 5-year panel data for a subset of indi-
cators (e.g., staff, patient volumes, and services provided)
and cross-sectional data on facility characteristics, equip-
ment availability, and pharmaceutical stocks. Retrospect-
ive panel data reflected fiscal years, which largely covered
2006 to 2010 for Zambia and 2007 to 2011 for Kenya and
Uganda. In instances where data were incomplete for a
subset of indicators, we used Amelia II software to create
50 imputed datasets. ABCE data collection and data pro-
cessing are detailed elsewhere [38].
In-depth descriptions of facility sampling approaches
have been previously published for Kenya, Uganda, and
Zambia [39–41], and additional detail country-specific
sampling strategies can be found in the Additional file 1:
Appendix S1. In sum, a two-step stratified random sam-
pling process occurred to construct nationally represen-
tative samples of health facilities for each country. The
first step entailed creating a sampling frame from which
subnational geographic units (districts for Uganda and
Zambia, and counties for Kenya) would be drawn. For
Uganda, one rural and one urban district were randomly
drawn from 10 regional boundaries commonly used by
household surveys in the country. For Kenya and
Zambia, counties and districts were grouped by geo-
graphic performance indicators derived from previous
surveys, and one subnational unit was randomly drawn
from each category. The second sampling step involved
sampling facilities from selected districts or counties
across a range of facility types identified for each coun-
try, in accordance with their health systems. Ministry of
Health facility inventories from 2011 in Kenya and
Uganda, and 2010 in Zambia, served as the facility sam-
pling frame source. For each country, this two-step sam-
pling process resulted in 18 to 22 districts or counties
selected through the district or county sampling frame,
and between approximately 180 and 270 facilities selected
through the facility sampling frame. For each country, a
predetermined number of facilities were randomly se-
lected from each facility type category within selected
districts or counties.
The final ABCE datasets for these countries included
625 facilities and 2973 facility-years. We excluded na-
tional hospitals, specialty facilities, dental clinics, and
pharmacies due to their substantive differences in ser-
vices offered and production processes. To identify
specialized facilities for exclusion, we used keyword
searches of survey administrator comments, as well as
manual examinations for facilities in the top and bot-
tom 5 % of the efficiency spectrum. We also excluded
facilities for which all 5 years of panel data were
missing. For our analysis, we used a total of 395 facil-
ities and 1900 facility-years.
We categorized facilities, inputs, and outputs into
consistently-defined groups to facilitate comparisons
across levels of care and countries. Facilities were
grouped into categories, or platforms, based on their
number of beds: 0 (no inpatient services), 1 to 15, 16 to
50, and more than 50 beds. For inputs, we used number
of full-time equivalent (FTE) facility staff disaggregated
by doctors, nurses, other medical personnel, and non-
medical personnel as measures of labor input, and num-
ber of beds as a measure of capital. For outputs, we used
the number of outpatient visits, ART visits, antenatal
care visits, births, and inpatient bed-days. ART visits
were comprised of the sum of pre-ART and ART visits.
Due to survey differences in Zambia, we estimated ART
visits using the number of ART patients seen at facilities
and multiplying these values by the average number of
patient visits extracted from clinical charts.
Structural quality adjustment
To account for potential variations in service quality, we
created structural quality-adjustment scores for each
output. These country- and output-specific scores were
calculated by determining whether each medical supply
or technology was available and functional in a given
facility, and then summing the total of these binary
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variables. The inclusion of a given output indicator was
informed by clinical guidelines, physician recommenda-
tions, and whether the indicator was captured through
the ABCE facility survey administered in each country.
For each facility, we divided their output-specific quality
sum by the highest quality value found within the country
and then multiplied their annual outputs by the facility’s
output-specific quality scores. Since quality scores could
not be computed over time, we applied the measure retro-
spectively over the panel data. The facility survey used in
Zambia slightly differed from the one administered in
Kenya and Uganda, so the indicators included for each of
Zambia’s outputs somewhat varied. Additional file 2:
Appendix S2 provides the full list of indicators used for
each output by country.
Analysis
Our study was conducted in three steps, namely (1)
estimating facility efficiency scores; (2) assessing facility
determinants of efficiency; and (3) predicting the poten-
tial for ART expansion. We also conducted a number of
sensitivity analyses, which are detailed in Additional file 3:
Appendix S3.
Estimating facility efficiency
We used a measurement approach recently designed for
quantifying technical efficiency in lower-resource settings,
referred to as the ensemble method (ENS). A description
of the ENS model and its merits are detailed elsewhere
[33], but in sum, it combines results from restricted
versions of Data Envelopment Analysis (rDEA) and
Stochastic Distance Function (rSDF) [11]. DEA computes
the ratio of weighted outputs to weighted inputs [42], and
then assigns efficiency scores to each facility relative to a
frontier set by facilities with the highest ratio of outputs to
inputs. The rDEA model involved placing weight restric-
tions for both inputs and outputs, which offered a solution
to a primary drawback – arbitrary weights – of traditional
DEA [43]. SDF is commonly used to estimate technical
efficiency for production processes with multiple outputs
(e.g., outpatients, inpatients, ART patients) [44]. rSDF,
which used a Cobb-Douglas multiple-output production
function, restricted variance to be greater than zero and
thus allowed interpretable measurement of error. As dem-
onstrated in an extensive simulation study [33], combining
results from rDEA and rSDF (the ENS model) provided
the most robust estimates of technical efficiency, particu-
larly when the underlying production function of facilities
are uncertain. Further, the ENS model helped to offset
some of DEA’s largest pitfalls: its tendency to underesti-
mate technical efficiency in contexts with a non-linear
multiple-output production function and its frequent
overestimation of efficiency when the distribution of
efficiency is uniform. For analyzing technical efficiency of
facilities in lower-resource settings, the ENS model per-
formance was viewed as the most preferred estimation
strategy [33].
For all facility-years of data, we used the ENS model
to estimate efficiency scores, which were based on the
median of 50 imputed datasets. In subsequent analyses,
we used efficiency scores from the most recent facility-
year, viewing this as a stronger measure of current cap-
acity for service expansion than multi-year averages of
efficiency.
To produce platform- and country-level averages of
efficiency, we applied weights to each facility efficiency
score, as derived from ABCE sampling frames.
Assessing facility determinants of efficiency
For each country, we logit-transformed facility efficiency
scores and multivariate regressions by pooling facilities
across platforms and countries, and accounted for nu-
merous facility covariates: urbanicity; ownership; elec-
trical connectivity; hosting of administrative meetings;
hosting of personnel training; the natural logarithm of
reported catchment population; fraction of FTEs absent
on the day of survey; and fraction of FTEs staffed by
doctors, nurses, and volunteers or externally funded
personnel. We also conducted bivariate regressions
stratified by platform for each country.
Predicting the potential for ART expansion
We estimated the potential for increased ART visits
across efficiency improvement scenarios, such that all fa-
cilities with ART and efficiency scores below a given
threshold increased their efficiency to reach that thresh-
old. For instance, in the 50 % efficiency improvement
scenario, we considered a world where facilities with
ART and efficiency scores below 50 % reached 50 % effi-
ciency. We assessed these scenarios by 10 percentage
point increments, from all facilities with ART reaching
at least 10 % efficiency to 100 % (all facilities are fully ef-
ficient). We then computed the potential number of
additional ART visits and corresponding percentage in-
creases in ART for each country.
For this analysis, potential for expanded ART was de-
fined by the radial, or proportional, expansion of all fa-
cility outputs. This parameter precluded options of
opening new ART clinics within facilities or output
transformation (e.g., increasing ART volumes by holding
inpatient services constant), both of which could addition-
ally scale up ART services. However, these approaches
require an influx or shifting of resources, and would not
capture the potential for maximizing inputs at facilities
that already provide ART. Instead, we sought to quantify
how much ART outputs could be increased, given ob-
served facility resources and service offerings, through
gains in efficiency.
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Uncertainly analysis
To propagate uncertainty for our estimates of facility effi-
ciency, we used bootstrap resampling, where we randomly
selected one of the 50 imputed datasets, i, and sampled
with replacement to create a bootstrap sample, b, with the
same dimensions as i. Since not all facility years in i were
represented in b, we ran rDEA on i with weight restric-
tions and a frontier defined by b. Similarly, for restricted
rSDF efficiency estimation, we calculated rSDF parameters
in b and applied them to i for bootstrap rSDF efficiency
scores [45]. Any efficiency score estimates exceeding
100 % were assigned a value of 100 %.
For each bootstrap resampling, we calculated ENS
efficiency estimates and scale-up of ART visits. In total,
we used 1000 boot-strapped samples to calculate 95 %
uncertainty intervals (UIs) for all estimates of technical
efficiency and further expansion for ART.
All analyses were conducted in R 3.2.2 and its Bench-
marking 0.26 package.
Role of funding
This work was supported by two grants funded by the Bill
& Melinda Gates Foundation: ‘Assessing the determinants
of cost-effectiveness of ART and HIV prevention pro-
grams in Kenya, Uganda and select states in India’ and the
‘Disease Control Priorities Network’. The funder was not
involved in data collection, analysis, or review of the final
results, nor did the funder have a role in the decision to
submit this manuscript for publication.
Results
Across countries, facility inputs and outputs varied
markedly (Table 1). Facility averages for staff and patient
volumes generally increased alongside facility size, but
within platforms, sizeable differences existed. For instance,
in Zambia, the second-largest and largest facilities aver-
aged about 7100 and 31,300 ART visits, respectively, but
each platform type also featured one facility with over
80,000 ART visits.
In calculating averages of technical efficiency across
platforms and countries, two main findings emerged
(Fig. 1): (1) average efficiency scores were relatively low
and (2) each country demonstrated massive within-
platform heterogeneity. Across all facilities, Uganda had
the highest average efficiency score (40 %; 95 % UI, 33–
47 %), followed by Zambia (39 %; 95 % UI, 37–49 %) and
Kenya (34 %; 95 % UI, 30–42 %). We found that 64 % of
facilities recorded efficiency scores of 50 % or lower, and
95 % of facilities fell below 80 % efficiency. Among facil-
ities which provided ART, average efficiency scores were
somewhat higher: 50 % (95 % UI, 48–62 %) in Uganda,
59 % (95 % UI, 53–67 %) in Zambia, and 51 % (95 % UI,
48–58 %) in Kenya. For facilities with ART, 45 % had effi-
ciency scores of 50 % or lower and 94 % performed below
80 % efficiency. For each country and platform, there were
a number of facilities with efficiency scores lower than
20 % and at least one facility scoring 85 % or higher.
Table 2 provides detailed comparisons of efficiency by
country and platform.
Based on our multivariate analysis of efficiency and
facility indicators (Tables 3 and 4), we found that most
indicators were not significantly related to facility effi-
ciency or did not show consistently significant associations
with facility efficiency scores across countries or plat-
forms. When stratified by platform, for instance, having a
high proportion of FTEs staffed by doctors had a signifi-
cant, positive association with higher levels of efficiency
among facilities with zero beds, whereas the opposite was
true – a significant, negative association with efficiency –
among facilities with 1 to 15 beds. The log of reported
catchment populations was significantly related to higher
efficiency for two facility sizes (zero beds and 1 to 15
beds), while this relationship was attenuated for larger
facilities. Among facilities with 1 to 15 beds and 16 to 50
beds, we found a significant, positive relationship between
public ownership and higher efficiency scores. On the
other hand, for facilities with 16 to 50 beds, having a high
fraction of FTEs staffed by volunteers or externally funded
personnel had a significant, negative relationship with
facility-level efficiency. When facilities were pooled across
platforms and stratified by country, a mixture of results
emerged. Across countries, facilities with 1 to 15 beds had
a significant, positive association with efficiency, whereas
a less consistent relationship was found for facilities with
16 to 50 beds. Three facility characteristics had significant,
positive associations with efficiency scores in Uganda:
public ownership, log of the facility catchment population,
and fraction of FTEs staffed by doctors. However, across
the other countries, these indicators were neither signifi-
cant nor consistently related to efficiency. In Zambia, the
fraction of FTEs staffed by volunteer or externally funded
personnel had a significant, negative relationship with
efficiency. Regression results from our bivariate analyses
were far less stable and conclusive, as detailed in Additional
file 4: Appendix S4.
Figure 2 illustrates the potential for ART expansion
across efficiency improvement scenarios. For the sce-
nario where all facilities with ART reached at least 50 %
efficiency, we estimated a 3 % (95 % UI, 1–9 %) increase
in annual ART visits in Kenya, 12 % (95 % UI, 1–23 %)
in Uganda, and 9 % (95 % UI, 2–21 %) in Zambia. If all
facilities with ART and efficiency scores less than 80 %
reached 80 % efficiency, we estimated a 33 % (95 % UI,
19–48 %) rise in Kenya, 62 % (95 % UI, 21–78 %) in
Uganda, and 33 % (95 % UI, 18–65 %) in Zambia. The
latter scenario, all facilities with ART reaching 80 % effi-
ciency, would equate to an additional 1.56 million ART
visits (95 % UI, 0.871–2.25 million) in Kenya, 1.28
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Table 1 Facility descriptive statistics, by country and platform
Indicator Kenya Uganda Zambia
0 beds 1–15 beds 16–50 beds > 50 beds 0 beds 1–15 beds 16–50 beds > 50 beds 0 beds 1–15 beds 16–50 beds > 50 beds
Facility
inputs
Doctors 0.1 (0–1) 0.2 (0–2) 0.9 (0–4) 20.1 (2–59) 0.4 (0–3) 0.1 (0–1) 0.6 (0–2) 13.9 (0–62) 0.2 (0–1) 0.1 (0–1) 0.4 (0–2) 5.8 (1–13)
Nurses 2.0 (0–9) 5.2 (1–28) 9.8 (2–33) 137.9 (4–429) 4.0 (0–24) 5.5 (1–23) 11.3 (3–26) 104.6
(18–311)
5.5 (1–15) 2.5 (0–17) 6.4 (0–23) 33.7 (8–94)
Other
medical
staff
1.5 (0–7) 4.2 (0–25) 7.9 (1–25) 57.4 (5–191) 2.3 (0–16) 2.1 (0–10) 6.9 (1–15) 46.3 (4–167) 7.5 (0–27) 9.0 (0–121) 14.8 (1–78) 48.5 (8–206)
Non-
medical
staff
2.0 (0–9) 5.2 (0–18) 12.0 (1–31) 82.0 (21–275) 7.4 (0–48) 4.0 (0–37) 8.1 (2–29) 59.0 (6–193) 4.8 (0–15) 2.6 (0–23) 7.2 (0–23) 51.6
(15–160)
Beds 0.0 (0–0) 7.6 (1–14) 28.1 (16–50) 279.7
(67–700)
0.0 (0–0) 7.2 (1–15) 28.3
(16–48)
227.1
(67–532)
0.0 (0–0) 6.1 (1–15) 23.2
(16–43)
153.3
(60–458)
Facility
outputs
Outpatient
visits
4664.0
(283–
26,402)
10,735.7
(720–62,178)
11,306.9
(672–42,050)
66,452.8
(159–231,853)
12,445.9
(475–77,544)
10,513.6
(120–26,477)
25,117.0
(1635–
130,604)
80,699.9
(4601–
261,697)
13,654.1
(216–27,697)
10,718.8
(445–41,608)
15,402.6
(0–39,846)
22,902.6
(0–93,205)
ANC visits 190.5
(0–2993)
961.2
(0–6821)
1196.4
(31–3821)
4,788.1
(76–12,622)
354.1
(0–10,690)
1517.9
(0–11,230)
4138.6
(128–17,658)
12,743.1
(282–86,176)
793.7
(0–3,439)
804.9
(0–6790)
1326.6
(0–5197)
1541.2
(0–4446)
ART visits 328.1
(0–7388)
1199.3
(0–19,663)
1858.5
(0–17,245)
15,422.2
(0–94,030)
4259.0
(0–68,101)
73.9
(0–2175)
1035.5
(0–13,466)
22,491.7
(0–304,272)
5678.1
(0–79,745)
2526.4
(0–75,415)
7107.5
(0–85,960)
31,337.5
(0–88,943)
Inpatient
visits
0.0 (0–0) 174.7
(0–1323)
1,949.3
(0–7920)
49,408.7
(2954–
149,208)
0.0 (0–0) 123.0
(0–2280)
2780.3
(0–15,894)
47,633.1
(176–172,859)
0.0 (0–0) 162.9
(0–1483)
963.3
(0–6310)
22,312.2
(380–63,637)
Deliveries 7.8 (0–84) 169.6
(0–1461)
349.7
(0–1244)
2785.5
(103–9175)
0.1 (0–3) 204.2
(0–1367)
517.9
(61–2380)
3410.1
(94–8428)
2.5 (0–36) 116.8
(0–1128)
520.4
(0–3730)
1196.6
(70–3127)
Percent of
facilities
providing
ART
14 % 31 % 46 % 65 % 13 % 82 % 32 % 83 % 29 % 15 % 36 % 89 %
Total number
of facilities
37 42 28 20 40 49 28 29 17 62 25 18
Averages of facility inputs and outputs are reported by country and platform, and the range for each group is reported within parentheses. ANC, antenatal care; ART, antiretroviral therapy
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million (95 % UI, 0.444–1.63 million) in Uganda, and
1.77 million (95 % UI, 0.884–4.43 million) in Zambia.
Table 5 details efficiency improvement scenarios and cor-
responding estimates of ART expansion by country. If all
facilities providing ART reached at least 80 % efficiency
for these countries, we estimated 459,000 new ART pa-
tients could be seen, in accordance with national recom-
mendations on ART visit frequency during the first year of
treatment [44–46].
Discussion
Our study showed that health facilities in Kenya,
Uganda, and Zambia had relatively low technical effi-
ciency, with each country averaging efficiency scores
below 50 %. Further examination revealed massive hetero-
geneity, with facilities registering efficiency scores ranging
from near 0 % to 95 % across levels of care. Most facility-
based indicators were not significantly or consistently
correlated with higher efficiency, suggesting that other
characteristics, such as management practices, may be
more closely linked to increased efficiency. In considering
facility potential for HIV service expansion, we assessed
the potential impact of efficiency gains, given observed re-
sources at facilities providing ART, across improvement
scenarios. For instance, if all facilities with ART and
efficiency scores below 80 % reached 80 % efficiency, we
predicted that ART visits could increase by 33 % in Kenya,
62 % in Uganda, and 33 % in Zambia. These results quan-
tify the capacity for improved resource use and further
ART scale-up in sub-Saharan Africa.
WHO recently updated its ART guidelines, recom-
mending that everyone living with HIV initiate ART [5].
This move toward universal HIV treatment aims to sig-
nificantly improve patient outcomes and curb transmis-
sion, yet, with stagnated HIV funding and millions more
now eligible for ART [2, 3, 5], policymakers face tough
decisions about how to pay for this influx of patients.
We found that facilities in Kenya, Uganda, and Zambia
could accommodate more ART initiates and continue care
for established patients if their efficiency improved. In fact,
if all facilities with ART reached at least 80 % efficiency in
these three countries, we estimated 459,000 new ART pa-
tients could be seen at these facilities. This would repre-
sent a 40 % rise in new ART patients and progress toward
reducing treatment gaps in Kenya, Uganda, and Zambia,
where an estimated 2.6 million people were living with
HIV and lacked ART in 2013 [1].
During the early to mid-2000s, global health initiatives
sought to quickly fund and roll-out HIV services in sub-
Saharan Africa [46]. These efforts, supported by a rapid
escalation of DAH [2, 3], were critical to slowing the
rampant spread of HIV and scaling up life-saving treat-
ment. However, the eight-fold increase of DAH during
this era has leveled off [2, 3], and HIV treatment now
more closely resembles that of chronic conditions, re-
quiring coordinated care within health systems to sup-
port both new and established ART patients. Improving
how programs produce HIV services and strengthening
their efficiency should now be front-and-center, particu-
larly as the focus of both global and national policy-
makers shifts to maximizing HIV investments and
building sustainable systems [4, 6].
Table 2 Average efficiency scores, by country and platform
Platform Kenya Uganda Zambia
Average (95 % UI) Average (95 % UI) Average (95 % UI)
All facilitiesa 34 % (30–42 %) 40 % (33–47 %) 39 % (37–49 %)
0 beds 32 % (24–44 %) 37 % (25–48 %) 44 % (38–60 %)
1–15 beds 44 % (37–53 %) 48 % (34–55 %) 42 % (38–53 %)
16–50 beds 43 % (39–49 %) 46 % (41–58 %) 39 % (34–54 %)
> 50 beds 52 % (45–67 %) 50 % (47–64 %) 65 % (48–72 %)
aNationally-weighted average. UI, uncertainty interval
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Fig. 1 Range of facility efficiency scores, by country and platform. Note: Each black bar represents a facility’s efficiency score for the most recent
year of facility data. The vertical line represents the average efficiency score across all facilities within a given platform and country
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Table 3 Multivariate analyses of facility determinants of efficiency pooled by country (A) and platform (B)
Covariate 0 beds 1–15 beds 16–50 beds > 50 beds
β P 95 % CI β P 95 % CI β P 95 % CI β P 95 % CI
Country Uganda
Kenya 0.22 0.453 (–0.40 to 0.81) –0.05 0.794 (–0.50 to 0.36) –0.42 0.378 (–1.40 to 0.53) a a a
Zambia –0.02 0.958 (–0.80 to 0.73) –0.28 0.287 (–0.80 to 0.24) –1.61* 0.012 (–2.90 to –0.38) 0.53 0.692 (–2.90 to 3.98)
Facility location Urban
Rural –0.35 0.138 (–0.80 to 0.12) –0.06 0.732 (–0.40 to 0.28) –0.18 0.554 (–0.80 to 0.43) 0.25 0.416 (–0.50 to 1.03)
Facility ownership Private
Public 0.36 0.185 (–0.20 to 0.90) 0.65* 0.004 (0.20 to 1.09) 1.98* < 0.001 (1.00 to 2.93) –0.79 0.092 (–1.80 to 0.20)
Facility regularly holds administrative
meetings
No
Yes 0.11 0.689 (–0.50 to 0.68) 0.17 0.474 (–0.30 to 0.63) 0.00 0.996 (–1.60 to 1.59) 2.15* 0.013 (0.80 to 3.55)
Facility connection to functional
electricity
No
Yes –0.38 0.180 (–0.90 to 0.18) –0.21 0.178 (–0.50 to 0.10) –0.13 0.699 (–0.80 to 0.54) 0.47 0.587 (–1.70 to 2.66)
Facility holds training sessions No
Yes –0.56* 0.038 (–1.10 to –0.03) –0.10 0.582 (–0.50 to 0.27) –0.13 0.726 (–0.90 to 0.60) 0.24 0.545 (–0.80 to 1.27)
Log of facility catchment population 0.16* 0.015 (0.00 to 0.29) 0.25* 0.001 (0.10 to 0.39) 0.16 0.330 (–0.20 to 0.48) –0.18 0.329 (–0.60 to 0.27)
Fraction of FTEs absent 0.75 0.140 (–0.30 to 1.74) –0.29 0.363 (–0.90 to 0.34) –0.92 0.149 (–2.20 to 0.34) 3.97 0.166 (–2.50 to 10.49)
Fraction of FTEs staffed by nurses 0.55 0.226 (–0.30 to 1.44) 0.10 0.802 (–0.70 to 0.87) –0.50 0.647 (–2.70 to 1.67) –1.91 0.279 (–6.10 to 2.32)
Fraction of FTEs staffed by doctors 3.21* 0.024 (0.40 to 5.98) –3.85* 0.017 (–7.00 to –0.69) –1.09 0.842 (–12.00 to 9.80) –2.73 0.551 (–14.40 to 8.93)
Fraction of FTEs staffed by volunteer or
externally funded personnel
0.03 0.912 (–0.60 to 0.62) –0.32 0.174 (–0.80 to 0.14) –1.11* 0.038 (–2.10 to –0.07) –1.00 0.092 (–2.30 to 0.26)
* Statistically significant
aAll facilities had the same value for the given covariate
CI, confidence interval; FTE, full-time equivalent
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Table 4 Multivariate analyses of facility determinants of efficiency pooled by country (A) and platform (B)
Covariate Kenya Uganda Zambia
β P 95 % CI β P 95 % CI β P 95 % CI
Platform 0 beds
1–15 beds 0.51* 0.050 (0.00 to 1.01) 0.63* < 0.001 (0.30 to 0.93) 0.63* 0.026 (0.10 to 1.19)
16–50 beds 0.04 0.914 (–0.70 to 0.75) 0.43* 0.025 (0.10 to 0.80) 0.22 0.468 (–0.40 to 0.83)
> 50 beds a a a 1.50* < 0.001 (0.70 to 2.29) 1.02* 0.048 (0.00 to 2.03)
Facility location Urban
Rural 0.01 0.961 (–0.50 to 0.51) 0.03 0.864 (–0.30 to 0.34) –0.04 0.861 (–0.60 to 0.46)
Facility ownership Private
Public 0.41 0.212 (–0.20 to 1.05) 0.78* 0.002 (0.30 to 1.26) 0.57 0.056 (–0.01 to 1.16)
Facility regularly holds administrative meetings No
Yes 0.17 0.570 (–0.40 to 0.77) 0.14 0.586 (–0.40 to 0.67) 0.43 0.304 (–0.40 to 1.27)
Facility connection to functional electricity No
Yes –0.17 0.640 (–0.90 to 0.56) –0.18 0.219 (–0.50 to 0.11) –0.33 0.138 (–0.80 to 0.11)
Facility holds training sessions No
Yes –0.46 0.172 (–1.10 to 0.20) –0.17 0.189 (–0.40 to 0.08) 0.70 0.094 (–0.10 to 1.53)
Log of facility catchment population 0.16 0.103 (– 0.01 to 0.35) 0.22 < 0.001 (0.10 to 0.32) 0.20 0.103 (–0.02 to 0.45)
Fraction of FTEs absent –0.94 0.105 (–2.10 to 0.20) –0.18 0.477 (–0.70 to 0.32) 0.59 0.410 (–0.80 to 2.00)
Fraction of FTEs staffed by nurses –0.39 0.597 (–1.80 to 1.06) –0.03* 0.937 (–0.70 to 0.68) 0.24 0.672 (–0.90 to 1.35)
Fraction of FTEs staffed by doctors –0.83 0.816 (–7.90 to 6.26) 3.40* 0.003 (1.20 to 5.60) –3.92 0.068 (–8.10 to 0.29)
Fraction of FTEs staffed by volunteer or
externally funded personnel
0.40 0.354 (–0.50 to 1.27) –0.28 0.322 (–0.80 to 0.28) –0.60* 0.047 (–1.20 to –0.01)
* Statistically significant
aAll facilities had the same value for the given covariate
CI, confidence interval; FTE, full-time equivalent
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Our analysis of potential determinants of efficiency
could not definitively pinpoint a set of facility drivers of
heightened technical efficiency across countries and plat-
forms. Reported facility catchment population, an indi-
cator of the population size a facility serves, was one of
the only determinants that had a significant, positive re-
lationship with higher levels of efficiency among smaller
facilities. This result is not necessarily surprising, as
smaller facilities (those with 15 or fewer beds) with big-
ger catchment populations may be located in areas
where few, if no other, facilities exist to support the pop-
ulations residing within them. Further, these facilities
may have to accommodate more patients without experi-
encing a corresponding increase in medical staff, which
could lead to higher efficiency scores. In many countries,
including Kenya and Uganda, staffing levels are estab-
lished by the Ministry of Health or other centralized
health agencies [47, 48], and thus are not easily amenable
to efficiency improvement, particularly at the facility level.
Facility ownership, specifically public or government own-
ership, was another indicator for which we observed sig-
nificant, positive associations with efficiency among
facilities with 1 to 15 beds and 16 to 50 beds. Kenya,
Uganda, and Zambia have all abolished or reduced user
fees for patients seeking care at public facilities, especially
for primary care and ART services [49–54]; such efforts to
minimize patient medical expenses may have contributed
to heightened utilization at public facilities and thus
higher levels of service production. Again, however, this
indicator – facility ownership – does not lend itself to
facility-level initiatives to address inefficiencies.
We subsequently view more operational components
of health service production as strong candidate areas
for intervention at the facility level. The Institute for
Healthcare Improvement emphasizes strengthening in-
ternal processes around the primary customer (patients)
[55]. For instance, tailoring HIV services around ART
patient stability, such as lengthening the time between
ART visits for stable patients, could free facility re-
sources for expanding HIV services or intensifying care
for less stable patients [56]. Routinely collecting and
reviewing data on facility operations may also help to
ensure that resources optimally align with patient de-
mand [57]. These data then can be used to more effect-
ively deploy resources where they are needed, and
identify opportunities to improve health service access
[9]. A recent UNAIDS report documents the potential
impact of ART efficiency gains at the facility level [6],
which include using HIV “hotspot” mapping to inform
facility resource allocation in Zimbabwe and integrating
HIV services with other health programs in Sudan. Ef-
forts to expand overall health system access and
utilization have been a primary emphasis of past effi-
ciency studies in sub-Saharan Africa, stressing that
heightened patient demand will in turn increase facility
efficiency [16, 19]. We fully agree that improving health
system use has numerous benefits; nevertheless, we do
not view increasing demand and facility efficiency as
mutually exclusive policy decisions. Instead, our findings
highlight the largely untapped potential for improving
within-facility processes to extend the reach of limited
resources.
Kenya Uganda Zambia
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Fig. 2 Predicted percent increases in ART visits across efficiency improvement scenarios, by country. Note: The darker line represents point
estimates for predicted percent increases in ART visits, given an efficiency improvement threshold, in each country, while the shaded areas
represent uncertainty intervals for point estimates. Efficiency improvement thresholds reflect the levels of technical efficiency sought by facilities
with efficiency scores below the given thresholds. At the 50 % efficiency improvement threshold, all facilities with efficiency scores below 50 %
would increase efficiency to 50 %; facilities with efficiency scores above 50 % would not experience increased efficiency. Percent increase in ART
visits represents the predicted increase in ART visits that could be produced, given observed facility resources, if all facilities below a given
efficiency improvement threshold reached that threshold. ART, antiretroviral therapy
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Table 5 Efficiency improvement scenarios and potential increase in ART visits in Kenya, Uganda, and Zambia
Efficiency score
improvement
threshold
Kenya Uganda Zambia
Potential percent increase
in ART visits (95 % UI)
Potential additional
ART visits (95 % UI)
Potential percent increase
in ART visits (95 % UI)
Potential additional ART visits
(95 % UI)
Potential percent increase
in ART visits (95 % UI)
Potential additional ART visits
(95 % UI)
10 % 0 (0–0.005) 0 (0–243) 0 (0–0) 0 (0–0) 0 (0–0.07) 0 (0–3730)
20 % 0.02 (0.005–0.1) 1080 (222–4620) 0.03 (0–0.06) 664 (0–1270) 0.2 (0.01–2) 11,100 (710–106,000)
30 % 0.3 (0.04–1) 1270 (1830–44,100) 2 (0–4) 38,800 (0–78,300) 2 (0.2–7) 117,000 (7130–333,000)
40 % 1 (0.2–4) 50,800 (8490–168,000) 5 (0.01–12) 104,000 (253–245,000) 5 (0.5–13) 267,000 (22,400–633,000)
50 % 3 (1–9) 142,000 (45,400–405,000) 12 (1–23) 241,000 (20,500–489,000) 9 (2–21) 456,000 (76,500–1,070,000)
60 % 9 (4–18) 432,000 (186,000–843,000) 27 (4–39) 557,000 (85,000–815,000) 14 (5–33) 718,000 (234,000–1,690,000)
70 % 20 (10–32) 924,000 (463,000–1,490,000) 43 (10–57) 903,000 (218,000–1,220,000) 21 (10–48) 1,140,000 (503,000–2,470,000)
80 % 33 (19–48) 1,560,000 (871,000–2,250,000) 62 (21–78) 1,280,000 (444,000–1,630,000) 33 (18–65) 1,770,000 (884,000–3,440,000)
90 % 50 (31–66) 2,330,000 (1,460,000–3,110,000) 81 (34–99) 1,690,000 (720,000–2,090,000) 49 (29–84) 2,590,000 (1,420,000–4,430,000)
100 % 67 (45–85) 3,120,000 (2,120,000–3,970,000) 101 (49–120) 2,110,000 (1,030,000–2,550,000) 65 (42–103) 3,460,000 (2,100,000–5,440,000)
Each efficiency improvement scenario reflects the potential percent increase in ART visits and additional ART visits that health facilities could produce, given observed resources, if all health facilities with efficiency
scores below a given efficiency threshold improved their efficiency score to that threshold. ART, antiretroviral therapy. UI, uncertainty interval
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Relatedly, increasing system efficiency needs to be
considered alongside goals for service equity and quality
[58]. Reaching maximum efficiency may not be every
facility’s goal, particularly those focused on serving hard-
to-reach populations or providing highly-specialized
medical services. In our study, we excluded a number of
these more specialized facilities, as we did not want to
assess their production levels alongside less comparable
facilities. Further, the view of greater technical efficiency
and equity as inherently divergent health system goals is
fading, particularly as plateaued HIV-specific DAH and
mounting funding gaps strengthen calls for achieving
‘more with less’ against AIDS [7, 31, 59]. In fact, given
current financial projections, UNAIDS stresses the need
for efficiency gains to effectively reach high-risk individ-
ual and populations who currently lack ART [6]. It is
also critical to ensure that facilities are not maximizing
efficiency at the expense of service quality. An important
avenue for improving both efficiency and quality is link-
ing ART patient outcomes, such as viral load measures
and program retention, with measures of efficiency. Fu-
ture work should seek to explicitly link patient outcomes
with the full range of facility inputs and outputs of
interest.
Limitations
This work should be viewed within the context of the
limitations encountered, which were largely due to data
issues and methodological challenges. First, facility data
quality varied across countries and between facilities.
We conducted extensive data cleaning procedures and
used multiple imputation to limit this bias [38], but it is
possible that inputs and outputs were not completely ex-
haustive or comparable. Second, for our analysis of effi-
ciency determinants, we sought to include a full range of
potential drivers of heightened efficiency, but some key
factors, such as personnel absenteeism, may not have
been adequately captured. Third, determining which
specialized facilities to exclude from our analysis was
largely informed by comments from survey administra-
tors, and thus may not reflect all conceivable outliers.
Fourth, our efforts to account for service quality were lim-
ited to structural facility indicators, as our datasets lacked
linkages between services provided and desired patient-
level outcomes such as viral load suppression. Our facility
datasets also included few indicators on facility process or
medical staff quality, such as competency tests, which
further limited our quality adjustments primarily to struc-
tural components. In addition, this proxy quality measure
was based on observations of facility supplies and equip-
ment at the time of survey and was then applied retro-
spectively to our panel data. This analytic necessity may
have resulted in skewed estimates of efficiency during earl-
ier facility years, an issue that contributed to our decision
to limit reported results to most recent facility-years. Fifth,
we were unable to account for case mix at the facility
level, an issue that may have resulted in underestimating
efficiency for facilities catering to severely ill patients. We
considered constructing a proxy indicator for facility case
mix based on patient clinical information such as CD4
count at ART initiation, particularly since a subset of
facilities in our analysis had linked, de-identified clinical
chart data for ART patients [35–37]. However, due to sub-
stantive sampling and chart data limitations (e.g., in Kenya
and Uganda, approximately 20 % of ART patients lacked
CD4 count records at initiation in 2012 [60]), we deter-
mined that its application for the present study risked
introducing notable bias. Future analyses should explore
avenues for synthesizing different sources of data, includ-
ing alternative facility data types or geospatial estimates,
with facility assessments of efficiency.
In terms of methodological limitations, our novel ap-
proach, an ensemble model of rDEA and rSDF [33], has
not been extensively tested on routine health system
data. The model was developed in a simulation environ-
ment to improve on past measurement techniques and
challenges posed by model choices [33]. By combining
results from rDEA and rSDF, we aimed to harness each
method’s strengths and offset their deficiencies [11, 33].
Second, our efficiency estimates reflected overall facility
production, which may not correspond with a facility’s
ART clinic efficiency levels [28]. We could not explicitly
assign outputs to ART clinics within facilities, but future
work should consider how efficiency may differ within fa-
cility sub-clinics. Finally, we assumed a demand for scaling
up ART alongside other health services (radial expansion)
and selected facility inputs, which may not necessarily re-
flect a country’s policy options for expanding ART or im-
proving efficiency. For instance, program managers may
target some facilities for increasing ART volumes while
keeping inpatient services constant, or policymakers may
introduce task-shifting initiatives to further elevate pro-
gram efficiency. It is possible that these approaches, if im-
plemented, could support greater ART expansion than
what we estimated; nonetheless, our model’s parameters
can be adjusted to account for production preferences.
Conclusions
More countries have committed to achieving universal
ART and global guidelines now stipulate treatment for
all people living with HIV, irrespective of their disease
progression. At a time when international HIV funding
has stagnated and health systems are preparing to accom-
modate millions of newly-eligible ART patients, stretching
each health dollar is vital. In applying novel methods de-
veloped to measure technical efficiency in LMICs, we
found that the majority of health facilities providing ART
in Kenya, Uganda, and Zambia could considerably expand
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ART services by increasing efficiency. Our findings em-
phasize the importance of how facility resources are used,
rather than their sheer quantity, and how maximizing
their use could notably extend the reach of life-saving
treatment to all populations affected by HIV.
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